Medications

FDA approves drug for most deadly form of tuberculosis

(HealthDay)—A new drug has been approved as part of a powerful, three-pronged treatment regimen for the most deadly strain of tuberculosis, the U.S. Food and Drug Administration announced Wednesday.

Diseases, Conditions, Syndromes

TB drug could reduce mortality for MDR-TB and XDR-TB cases

Results from an observational study evaluating a new anti-TB drug have found that the treatment can improve outcomes and reduce mortality among patients with both MDR-TB and XDR-TB.

Oncology & Cancer

The challenges of cancer vaccines

The first therapeutic cancer vaccine has now been approved by the FDA, and a diverse range of therapeutic cancer vaccines directed against a spectrum of tumor-associated antigens are currently being evaluated in clinical ...

page 10 from 16